Higashi K, Tani K, Hayashi T, Hiraiwa T, Takeuchi Y, Kimura M, Kaneda M, Sakai T, Namikawa S, Kusagawa M
Nihon Kyobu Geka Gakkai Zasshi. 1989 Mar;37(3):404-10.
From 1955 through 1987, 64 cases underwent operation at Mie University Hospital for carcinoma of the lung invading the chest wall (p-T3). According to the classification by Mishina et al, the extent of tumor invasion of the chest wall was p3a-b in 63%, p3c in 18%, and p3d in 19%. Histologically, the tumors were epidermoid carcinoma in 565, adenocarcinoma in 31%, large cell carcinoma in 11%, and small cell carcinoma in 2%. The post surgical staging of N factor was N0 in 39%, N1 in 33%, and n2 in 28%. Extrapleural resection was performed in 27 cases and extended resection (en block resection of chest wall and lung) was performed in 30 cases with an operative mortality of 0%. The actuarial three-year survival rate (Kaplan-Meier method) for patients with p3d was 18.2% but three-year survival for patients with p3a-b and p3c was more than 30%. In spite of p3a-b, however, four-year survival for patients without extended resection was decreased to 11.6%. Four-year survival of patients with adenocarcinoma, epidermoid carcinoma, and large cell carcinoma was 5.9%, 28.4% and 75% respectively, lymphatic metastases reduced survival, with a three-year survival rate of 52.8% for patients with N0 disease and 8.35 for those with N2 disease. Among patients with extended resection, four-year survival for patients 60 years of age of less was 50.8%, greater than the 13.3% four-year survival for the patients more than 61 years of age. We conclude that long-term survival can be influenced by the extent of tumor invasion. In factor, histologic type, and the patient's age, and that extended resection and adjuvant therapy should be applied for treatment of lung cancer with chest wall invasion.
1955年至1987年期间,64例肺癌侵犯胸壁(p-T3)患者在三重大学医院接受了手术。根据Mishina等人的分类,胸壁肿瘤侵犯程度为p3a-b的占63%,p3c的占18%,p3d的占19%。组织学上,肿瘤为鳞状细胞癌的占56%,腺癌的占31%,大细胞癌的占11%,小细胞癌的占2%。术后N分期为N0的占39%,N1的占33%,N2的占28%。27例行胸膜外切除术,30例行扩大切除术(胸壁和肺整块切除),手术死亡率为0%。p3d患者的精算三年生存率(Kaplan-Meier法)为18.2%,而p3a-b和p3c患者的三年生存率超过30%。然而,尽管是p3a-b,未行扩大切除术患者的四年生存率降至11.6%。腺癌、鳞状细胞癌和大细胞癌患者的四年生存率分别为5.9%、28.4%和75%,淋巴结转移降低了生存率,N0疾病患者的三年生存率为52.8%,N2疾病患者的为8.35%。在接受扩大切除术的患者中,60岁及以下患者的四年生存率为50.8%,高于61岁以上患者13.3%的四年生存率。我们得出结论,长期生存可能受肿瘤侵犯程度、组织学类型和患者年龄的影响,对于侵犯胸壁的肺癌应采用扩大切除术和辅助治疗。